Today: 8 February 2026
Subscribe
Browse Category

Stock Market News 17 October 2025

Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

RANI Stock Price Explodes on Deal News Rani Therapeutics’ stock price skyrocketed on Friday, Oct. 17, after the company unveiled a major partnership and funding news. In pre-market trade, RANI jumped about 150% and continued to rally after the market open tipranks.com. The stock, which had closed at just $0.47 the prior day, briefly hit approximately $1.37 per share – nearly a 3× gain in value google.com. By midday, shares were still trading around the $1.30 level, up almost +180% on the day. This stunning one-day move snapped RANI out of penny-stock territory and back above the Nasdaq’s $1 minimum
17 October 2025
·
Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third Stock Rallies After Turbulent Week Fifth Third Bank logo is seen in this illustration taken April 23, 2024 (REUTERS/Dado Ruvic). Fifth Third’s stock is bouncing back to end a volatile week. By midday Friday (Oct. 17), FITB shares were trading around $41–$42, up roughly 2–3% after the bank’s strong earnings report beat expectations reuters.com. The mini-rally follows a sharp selloff in regional bank stocks just one day earlier: on Thursday, Fifth Third fell about 4% as part of a broader rout fueled by credit worries ts2.tech. News of surprise loan losses at two peer banks – Zions and
17 October 2025
··
SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

Q3 Earnings Recap: Resilient Results Amid Oil Slowdown SLB’s third-quarter 2025 results, released on Oct 17, showed better-than-expected profitability even as industry conditions softened. The company earned $0.69 per share (adj.) for Q3, topping estimates of $0.66 Tipranks. Revenue came in at $8.93 billion, essentially on target Tipranks. Both metrics were down modestly from a year ago (EPS was $0.89, revenue $9.16 B in Q3 2024) as global drilling activity has cooled. CEO Olivier Le Peuch described the quarter as “resilient,” noting SLB expanded its EBITDA margins and generated $1.8 B in free cash flow, thanks to efficiency gains Investing Investing. North America
17 October 2025
···
American Express Raises Forecasts Amid Spending Boom – Is AXP Stock Poised to Soar?

American Express Raises Forecasts Amid Spending Boom – Is AXP Stock Poised to Soar?

AXP Stock Near Highs on Earnings Momentum American Express shares have been on a tear in recent months. The stock surged roughly 50% off its April lows following market jitters over tariffs, ultimately reaching a record high of $349.19 earlier this month Schwabnetwork. After peaking, AXP saw a quick 9.5% pullback over 14 trading days to around $315, before buyers stepped in. Notably, a single-session jump of +3% on Tuesday, October 14 helped break the downtrend and lifted the stock back above its 21-day moving average near $329 Schwabnetwork. As of October 17, AXP hovers around the $330 level, putting
17 October 2025
··
Shell’s $2 Billion Nigeria Gas Gamble Ignites LNG Boom Amid $8 B Investment Surge

Shell’s Bold $2 Billion Bet and Oil Price Twist: What’s Next for Shell Stock?

Shell Stock Climbs Amid Market Volatility Shell plc’s stock price held firm on Friday at around £26.72 per share, capping off a choppy week on a positive note. The shares inched up ~0.2% on the dayhl.co.uk – a notable rebound after slipping earlier when global markets sold off. Over the past few sessions, Shell’s price oscillated between roughly £26.3 and £26.8 as investors digested oil price swings and company newsreuters.com. Despite this volatility, Shell’s stock gained roughly 3–4% on the weekhl.co.uk, outpacing the broader FTSE 100 which fell to two-week lows amid banking and commodity weaknessreuters.com. Traders say resilient oil
17 October 2025
·
Lloyds Share Price: Can the FTSE‑100 Bank’s Value Keep Surging or Is a Crash Coming?

Lloyds Stock Nears Decade High as Bank Shrugs Off £2bn Scandal Hit

Market Rally Puts Lloyds Near Record Levels Lloyds Banking Group (LON: LLOY) stock is flirting with decade highs after an impressive 2025 rally. Shares in the UK’s largest retail bank traded around 85 pence on 17 October – roughly unchanged from Thursday’s close – having recovered from a sharp fall earlier in the daysharesmagazine.co.uk. In morning trade, Lloyds tumbled nearly 3% to about 82p amid a broad sell-off in financials, as fears over U.S. regional bank loan troubles rattled global marketsreuters.com. By afternoon, however, Lloyds had clawed back those losses, reflecting its relative strength in a volatile session. The FTSE
17 October 2025
·
Biotech Breakthrough: GRAIL (GRAL) Stock Surges on New Cancer-Detection Data

GRAIL (GRAL) Rockets to Record High on Samsung Mega-Deal and Cancer Test Breakthrough

Samsung Partnership Sparks Stock Surge GRAIL, Inc. (NASDAQ: GRAL) shares soared to record highs this week after the company announced a strategic collaboration with Samsung. On October 16, GRAIL revealed a binding agreement in which Samsung C&T and Samsung Electronics will invest $110 million into GRAIL at $70.05 per sharets2.tech. In return, Samsung C&T gains exclusive rights to distribute GRAIL’s Galleri multi-cancer early detection blood test in South Korea, with plans to expand to Japan and Singaporets2.tech. Samsung Electronics will explore technology tie-ups, integrating its digital health platforms and AI with GRAIL’s cancer-detection technologytradingview.comprnewswire.com. Investors cheered the deal as a major
17 October 2025
·
Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?

Rolls-Royce Stock Skyrockets to Record High – Will It Climb Higher or Run Out of Fuel?

Stock Price Soars to Multi-Year High Rolls-Royce’s stock has been on fire in 2025. The share price has climbed ~124% over the past 12 months, far outpacing the broader marketts2.tech. After languishing below £1 in 2020’s crisis, the stock took flight as global air travel rebounded and defence spending surged. By late September this year, Rolls-Royce shares hit approximately 1,196p, which TS2.tech notes is a multi-year (and effectively all-time) high for the companyts2.tech. This remarkable rally – about +100% year-to-date – has elevated Rolls-Royce into the top tier of London-listed companies, with a market capitalization near £99–100 billionts2.tech. It’s now among
17 October 2025
Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Stock Hits a 52-Week Low on Legal Woes Kenvue’s shares collapsed to an all-time low since their mid-2023 IPO, closing around $14 after Thursday’s 13.2% plunge stocktwits.com. The one-day drop – Kenvue’s worst on record – was triggered by headline risks that blindsided investors. By early Friday, October 17, the stock stabilized slightly (up about 0.6% in pre-market trading) after the rout stocktwits.com. Still, at roughly 40% below its IPO price, the Johnson & Johnson spinoff has seen its market capitalization shrink to about $30–31 billion reuters.com. This dramatic sell-off came despite broader markets being relatively calm – the S&P
17 October 2025
··
Akanda Corp (AKAN) Soars on Telecom Expansion – What It Means for Investors

Akanda Corp (AKAN) Soars on Telecom Expansion – What It Means for Investors

Stock Price & Recent Performance Akanda’s stock has been on a rollercoaster. After languishing through 2024 “flying under the radar” stocktitan.net, AKAN came alive this October. The share price erupted over 100% intraday on Oct. 1 amid a burst of interest in the company’s new direction stocktitan.net. Traders cite the ultra-low float – under 0.73 million shares – as a catalyst for these outsized swings. When positive news hits a micro-cap with so few shares available, “even modest buying pressure can create explosive moves” stocktitan.net. Conversely, any wave of selling can also trigger sharp pullbacks, making AKAN a volatile ride.
17 October 2025
Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Stock Hits Multi-Month Low Amid Legal Fallout Jefferies shares have been on a wild ride in recent weeks, culminating in a steep plunge on October 16. The stock sank intraday to about $50 – territory not seen in over four months – before closing at $48.80, down over 10% for the day stockinvest.us. The selloff erased roughly one-quarter of Jefferies’ market value in just two weeks, capping a slide from the mid-$60s in late September ts2.tech. The immediate trigger for the latest drop was mounting scrutiny over Jefferies’ exposure to a client’s bankruptcy and the wave of shareholder lawsuits that
17 October 2025
·
Safe & Green (SGBX) Roars Back: Nasdaq Lifeline and AI Pivot Fuel Wild Stock Ride

Safe & Green (SGBX) Roars Back: Nasdaq Lifeline and AI Pivot Fuel Wild Stock Ride

Nasdaq Compliance Triggers Relief Rally Safe & Green Holdings Corp. regained compliance with Nasdaq’s listing rules in early October 2025, temporarily boosting its microcap stock price. A week ago, Safe & Green Holdings Corp. (NASDAQ: SGBX) was on the brink of losing its Nasdaq listing – today it’s back in the game, though not without turbulence. The Miami-based modular building and green construction company secured a lifeline on Oct. 9 by regaining compliance with Nasdaq’s $1 minimum bid price requirement, after drastic capital moves to bolster its share price ts2.tech. Nasdaq confirmed the company met listing rules as of Oct.
17 October 2025
··
$100 B Bank Fraud Scandal Triggers Global Market Rout – DAX Sinks Below 24,000 Amid ‘Cockroach’ Fears

$100 B Bank Fraud Scandal Triggers Global Market Rout – DAX Sinks Below 24,000 Amid ‘Cockroach’ Fears

U.S. Bank Fraud Shocks Ignite Global Selloff Investors worldwide were rattled after back-to-back fraud scandals at two U.S. regional banks triggered a crisis of confidence in credit markets. On October 16, Utah-based Zions Bancorporation revealed a sudden $50 million loss on two commercial loans tied to alleged borrower fraud – an “ostensibly isolated” hit that nevertheless sent its shares plunging 12–13%, the worst one-day drop in six monthsts2.techts2.tech. Phoenix-based Western Alliance Bancorp – a peer that lent to related borrowers – fell about 10–11% in sympathy after disclosing its own fraud lawsuit filed in Augustts2.tech. “The fact another respected regional bank
17 October 2025
Deutsche Bank Stock Plunges Again as Global Credit Jitters Flare – What Experts Predict Next

Deutsche Bank Stock Plunges Again as Global Credit Jitters Flare – What Experts Predict Next

Market Shock Hits Deutsche Bank A fresh wave of fear swept through global markets in recent days, and Deutsche Bank’s stock was not spared. On Friday (Oct. 17), shares of Germany’s largest lender plunged over 6%, falling to roughly €28.6welt.de. By midday, Deutsche Bank was deep in the red – occupying the bottom tier of the DAX index – as the overall DAX slumped about 2%welt.de. This sharp drop erased roughly €1.9 from the share price in one day. It marked the latest setback for the bank’s stock, which had been climbing steadily for months before abruptly reversing course this
17 October 2025
·
Nasdaq Warning and EV Ambitions: Carbon Revolution (CREV) Races to Reinvent Itself

Nasdaq Warning and EV Ambitions: Carbon Revolution (CREV) Races to Reinvent Itself

Nasdaq Compliance Deadlines Loom Carbon Revolution is under intense pressure to shore up its Nasdaq listing status. On July 16, the Australia-based company disclosed it had received a non-compliance notice for falling short of Nasdaq’s minimum shareholder equity requirement of $10 million stocktitan.net. The deficiency was evident in its FY2024 financials, and Nasdaq gave Carbon Revolution 45 days to submit a plan to regain compliance stocktitan.net. If that plan is accepted, the company could get up to 180 days (until ~Nov. 26, 2025) to rebuild its equity base or otherwise meet listing standards stocktitan.net. Failure to do so would put
17 October 2025
··
Barclays Shares Slump 5% in FTSE 100 Rout – Is It a Golden Buying Opportunity?

Barclays Shares Slump 5% in FTSE 100 Rout – Is It a Golden Buying Opportunity?

FTSE 100 Turmoil Drags Barclays Down A wave of global banking jitters swept through markets in mid-October, and Barclays was caught in the undertow. On Friday, Oct. 17, the FTSE 100 index plunged roughly 1.5% at the open as investors reacted to trouble at two U.S. regional banksts2.tech. Barclays (LON:BARC) shares tumbled about 5% in the sell-off – the steepest drop among blue-chip constituentsproactiveinvestors.co.uk. The stock fell from around 379p to the mid-350s pence range intradayuk.investing.com, erasing about a month’s worth of gains in a single session. What spooked the market? The trigger was bad news across the Atlantic: Zions
17 October 2025
Credit ‘Cockroach’ Jitters Shake Markets: Stocks Slide Globally as Gold Hits Record High

Credit ‘Cockroach’ Jitters Shake Markets: Stocks Slide Globally as Gold Hits Record High

Banking Scare Sparks Global Selloff A new bout of credit jitters is roiling global markets, sparked by trouble at a pair of midsize U.S. banks. On Thursday, Utah-based Zions Bancorporation and Phoenix-based Western Alliance Bancorp revealed they face hefty losses on problematic loans – including a $50 million charge-off at Zions and a $100 million bad loan at Western tied to alleged borrower fraudtheguardian.com. While relatively small banks (each under $10 billion market cap), the revelations sent shockwaves through the financial sector. “The event drew inevitable comparisons to the regional bank stress that followed the collapse of Silicon Valley Bank (SVB) in 2023,”
17 October 2025
·
Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Market Selloff Fueled by Loan Fraud Fears Wall Street skidded into the red late this week as fear of hidden loan losses gripped the market. On Thursday (Oct. 16), the Dow, S&P 500, and Nasdaq all closed sharply lower – around 0.5%–1% down each for the day reuters.com – after early gains evaporated. The Dow Jones index gave up roughly 300–400 points, about 0.65%, by the closing bell reuters.com. The reversal came suddenly after midday news of loan problems at two regional banks hit traders’ screens. “Signs of weakness in regional banks spooked investors already on edge,” Reuters noted, especially
17 October 2025
IBPS SO Prelims Result 2025 Out: 1000+ Bank Vacancies & Experts Bullish on Bank Stocks

IBPS SO Prelims Result 2025 Out: 1000+ Bank Vacancies & Experts Bullish on Bank Stocks

IBPS SO Prelims Results Released on IBPS Portal The IBPS has officially released the Specialist Officer (SO) Preliminary Exam 2025 results on its website, bringing relief and closure to thousands of candidates who took the test. The results went live on October 17, 2025, and applicants can now log in to the IBPS portal (ibps.in) to view their statusmoneycontrol.com. To access the score, candidates must enter their Registration/Roll Number and Password or Date of Birth, along with a captcha codetimesofindia.indiatimes.com. The result page shows key personal details (name, roll number, category, etc.) and whether the candidate has qualified for the
17 October 2025
Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

In summary, Artiva Biotherapeutics stock has erupted in October 2025 on the back of a major FDA Fast Track win and renewed optimism around its NK-cell therapy for RA. The latest developments – from surging share price and volume to analyst projections of multi-fold upside – underscore the high stakes and high hopes riding on AlloNK’s success. For biotech investors and observers, ARTV will be a stock to watch closely in the coming months, as upcoming trial data and FDA feedback chart the next chapter for this promising yet still speculative biotech play. Latest Stock Price and Trend Analysis 247marketnews.com
17 October 2025
·
1 … 1,116 1,117 1,118 1,119 1,120 … 1,174

Stock Market Today

Texas Instruments stock price slips despite chip rally; what TXN holders watch into Monday

Texas Instruments stock price slips despite chip rally; what TXN holders watch into Monday

8 February 2026
New York, Feb 7, 2026, 17:30 EST — Market closed. Texas Instruments Inc shares fell 1.13% on Friday to close at $221.44, underperforming a broad market surge and ending the session about 3% below a 52-week high set earlier this week, according to market data. (MarketWatch) The gap was noticeable because chip stocks ripped higher on bets that Big Tech’s new spending targets will feed demand for data-center components, lifting Nvidia, AMD and Broadcom and pushing the PHLX semiconductor index up 5.7%. “This trade has been volatile… but I think there’s enough evidence that there’s real demand for AI products,”
Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop